openPR Logo
Press release

Lysosomal Storage Disease Market Trends, Share, Industry Size, Growth 2020 to 2026

06-25-2020 03:25 PM CET | Health & Medicine

Press release from: Orion Market Research

Lysosomal Storage Disease Market

Lysosomal Storage Disease Market

The global lysosomal storage disease market is anticipated to grow at a significant rate during the forecast period (2020-2026). Lysosomal storage disease comes under rare diseases. The number of incidences for the disease is around 1 in 7,700 according to the Gaucher’s Disease Foundation. The disease has several symptoms thus it is difficult to identify and diagnose.

Request a Free Sample of our Report on Lysosomal Storage Disease Market: https://www.omrglobal.com/request-sample/lysosomal-storage-disease-market

There are more than 50 types of lysosomal storage disease which are caused by the lack of enzymes. The different types of lysosomal storage diseases include Gaucher’s disease, Fabry disease, Niemann-pick disease, hunter syndrome, Tay-Sachs disease and more. These diseases affect different body parts such as Gaucher’s disease affect the liver and cause blood and bone problems. Tay-Sachs disease cause fatal mental and physical distortions.

The symptoms of the disease can vary from the type of lysosomal storage disease. The general symptoms are observed in the bones and joints, central nervous system, eyes, heart, kidney and lungs. The variation of the symptoms causes difficulty in the diagnosis of the disease. The diagnosis may take years for the physician to confirm the lysosomal storage disease, which is diagnosed on the basis of the pattern of symptoms observed. Gaucher’s disease can be diagnosed much easily by a simple blood test at the nearest local hospital. The efforts are put in for the research and development to diagnose the lysosomal storage disease. The specialized testing laboratories have been made in which the disease could be diagnosed. The lysosomal storage disease treatment does not have any cure for lysosomal storage disease. The researchers are putting in constant efforts to find a solution that would address the underlying causes rather than just treating the disease.

The treatment of disease options isvery expensive. These options include bone marrow transplantation, substrate reduction therapy, and enzyme replacement therapy. The complications and technology required for these treatments make the treatment of the disease expensive. Researchers are trying to find more affordable treatment for all kinds of lysosomal storage diseases. The constant development and research put together for the diagnosis and treatment of the disease would result in the growth of the lysosomal storage disease market.

A Full Report of Lysosomal Storage Disease Market is Available at https://www.omrglobal.com/industry-reports/lysosomal-storage-disease-market

Global Lysosomal Storage Disease Market

By Type
• Gaucher Disease
• Pompe Disease
• Tay-Sachs Disease
• Fabry Disease
• Other (Cystinosis and Krabbe Disease)

By Treatment
• Enzyme Replacement Therapy
• Substrate Reduction Therapy
• Stem Cell Transplant

Global Lysosomal Storage Disease Market Segmentation by Region

North America
• United States
• Canada

Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of the Asia-Pacific

Rest of the World
• Middle East & Africa
• Latin America

Company Profiles
• Actelion Pharmaceuticals, Ltd. (A Part of Johnson & Johnson Service, Inc.)
• Alexion Pharmaceuticals, Inc.
• Amicus Therapeutics, Inc.
• AMO Pharma, Ltd.
• Arena Pharmaceuticals, Inc.
• BioMarin Pharmaceuticals, Inc.
• Chiesi Farmaceutici SpA
• Eli Lilly Co.
• Horizon Therapeutics, Inc.
• Leadiant Biosciences, Inc.
• Pfizer, Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/lysosomal-storage-disease-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lysosomal Storage Disease Market Trends, Share, Industry Size, Growth 2020 to 2026 here

News-ID: 2080377 • Views:

More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033. Road Marking Paint Market Overview The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period. Outboard Boat Market Overview The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033. Mobile Ticketing Market Overview The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033. Metal Alloy Market Overview The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and